Geron Corporation struggles with negative ROIC, while Exelixis shows strong capital efficiency

From Financial Modeling Prep: 2024-12-28 16:00:05

Geron Corporation (NASDAQ:GERN) faces challenges with a negative ROIC of -68.21%, indicating struggles to generate returns on invested capital. Stem, Inc. (STEM) also has a negative ROIC of -147.16%, while Agenus Inc. (AGEN) shows a positive ROIC of 111.42%, surpassing its WACC. Exelixis, Inc. (EXEL) demonstrates strong capital efficiency with a ROIC of 17.91% and a high ROIC to WACC ratio of 2.63, making it an attractive investment option.



Read more at Financial Modeling Prep:: Geron Corporation’s Financial Analysis in the Biop…